Pfizer Stock Analysis

PFE -  USA Stock  

USD 52.54  1.00  1.94%

The latest surge in Pfizer short term price appreciation may encourage shareholders to take a closer look at the company as it is trading at a share price of 52.54 on 43,964,900 in trading volume. The company executives have successfully maneuvered the company at convenient times to take advantage of all market conditions in December. The stock standard deviation of daily returns for 90 days investing horizon is currently 2.72. The current volatility is consistent with the ongoing market swings in December 2021 as well as with Pfizer unsystematic, company-specific events.
Please check Your Equity Center.

Pfizer Stock Analysis 

 
Refresh
The Pfizer stock analysis report makes it easy to digest most publicly released information about Pfizer and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Pfizer Stock analysis module also helps to analyze the Pfizer price relationship with some important fundamental indicators such as market cap and management efficiency.

Pfizer Stock Analysis Notes

About 67.0% of the company shares are owned by institutional investors. The book value of Pfizer was at this time reported as 13.49. The company has Price/Earnings To Growth (PEG) ratio of 0.01. Pfizer Inc next dividend is scheduled to be issued on the 27th of January 2022. The entity had 3:1 split on the 17th of November 2020. Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 78500 people. To find out more about Pfizer Inc contact Ian Read at 212 733-2323 or learn more at www.pfizer.com.

Pfizer Inc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Pfizer's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Pfizer Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
About 67.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Acquisition by Jennifer Damico of tradable shares of Pfizer subject to Rule 16b-3

Pfizer Inc Upcoming and Recent Events

Earnings reports are used by Pfizer to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Pfizer previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report8th of February 2022
Next Earnings Report3rd of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End8th of February 2022
Last Quarter Report30th of September 2021
Last Earning Announcement31st of December 2020

Pfizer Largest EPS Surprises

Earnings surprises can significantly impact Pfizer's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
1999-07-19
1999-06-300.170.190.0211 
1998-10-13
1998-09-300.190.17-0.0210 
1998-07-09
1998-06-300.150.170.0213 
View All Earnings Estimates

Pfizer Thematic Classifications

In addition to having Pfizer stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Robots And Drones IdeaRobots And Drones
Cross-sector firms and funds that develop or invest in technology that can replicate repetitive human actions
Healthcare IdeaHealthcare
USA Equities from Healthcare industry as classified by Fama & French
Drugs IdeaDrugs
Drug manufacturing and delivery

Pfizer Market Capitalization

The company currently falls under 'Mega-Cap' category with total capitalization of 296.3 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pfizer's market, we take the total number of its shares issued and multiply it by Pfizer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Pfizer Profitablity

Pfizer's profitability indicators refer to fundamental financial ratios that showcase Pfizer's ability to generate income relative to its revenue or operating costs. If, let's say, Pfizer is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Pfizer's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Pfizer's profitability requires more research than a typical breakdown of Pfizer's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 28.68 %, which may imply that it executes well on its competitive polices and has reasonable control over its expenses and variable costs. This is very large. In the same way, it shows Net Operating Margin of 39.38 %, which entails that for every 100 dollars of revenue, it generated 0.39 of operating income.
Last ReportedProjected for 2022
Return on Investment 8.11  10.17 
Return on Average Assets 5.38  5.83 
Return on Average Equity 13.70  14.53 
Return on Invested Capital 0.24  0.22 
Return on Sales 0.39  0.35 

Management Efficiency

The entity has Return on Asset of 7.78 % which means that on every $100 spent on asset, it made $7.78 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 27.75 %, implying that it generated $27.75 on every 100 dollars invested. Pfizer management efficiency ratios could be used to measure how well pfizer inc manages its routine affairs as well as how well it operates its assets and liabilities. Pfizer Return on Average Assets are projected to increase slightly based on the last few years of reporting. The past year's Return on Average Assets were at 5.38. The current year Return on Average Equity is expected to grow to 14.53, whereas Return on Invested Capital is forecasted to decline to 0.22. Pfizer Current Assets are projected to decrease significantly based on the last few years of reporting. The past year's Current Assets were at 40.33 Billion. The current year Tax Assets is expected to grow to about 5.8 B, whereas Goodwill and Intangible Assets are forecasted to decline to about 84.3 B.
Last ReportedProjected for 2022
Book Value per Share 10.20  10.04 
Enterprise Value over EBIT 17.25  19.97 
Enterprise Value over EBITDA 12.96  13.91 
Price to Book Value 3.95  3.64 
Tangible Assets Book Value per Share 11.87  11.54 
Enterprise Value306.7 B295 B
Tangible Asset Value66.1 B70 B

Technical Drivers

As of the 26th of January, Pfizer holds the Semi Deviation of 1.97, coefficient of variation of 737.66, and Risk Adjusted Performance of 0.119. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pfizer, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Pfizer Inc, which can be compared to its competitors. Please check Pfizer Inc information ratio, as well as the relationship between the value at risk and expected short fall to decide if Pfizer Inc is priced some-what accurately, providing market reflects its current price of 52.54 per share. Given that Pfizer has jensen alpha of 0.2942, we recommend you to check out Pfizer Inc's recent market performance to make sure the company can sustain itself at a future point.

Pfizer Inc Price Movement Analysis

The output start index for this execution was one with a total number of output elements of sixty. The Simple Moving Average indicator is calculated by adding the closing price of Pfizer for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Pfizer Inc short-term fluctuations and highlight longer-term trends or cycles. View also all equity analysis or get more info about simple moving average overlap studies indicator.

Pfizer Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Pfizer insiders, such as employees or executives, is commonly permitted as long as it does not rely on Pfizer's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Pfizer insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Pfizer Outstanding Bonds

Pfizer issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pfizer Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pfizer bonds can be classified according to their maturity, which is the date when Pfizer Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
MaturityCouponRating
AMERICAN HOME PRODS03/01/20237.25
AA
PFIZER INC 7203/15/20397.2
AA
PFIZER INC 4306/15/20434.3
AA
PFIZER INC 306/15/20233.0
AA
PFIZER INC 4405/15/20444.4
AA
PFIZER INC 3405/15/20243.4
AA
PHARMACIA CORP 67512/15/20276.75
AA
PHARMACIA CORP 6612/01/20286.6
AA

Pfizer Predictive Daily Indicators

Pfizer intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Pfizer stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Pfizer Forecast Models

Pfizer time-series forecasting models is one of many Pfizer's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pfizer's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Pfizer Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Pfizer stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pfizer shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Pfizer. By using and applying Pfizer Stock analysis, traders can create a robust methodology for identifying Pfizer entry and exit points for their positions.
Last ReportedProjected for 2022
Operating Margin 21.14  23.61 
EBITDA Margin 26.43  27.49 
Gross Margin 71.33  70.86 
Profit Margin 20.65  20.68 
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 78500 people.

Current Pfizer Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pfizer analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Pfizer analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
58.92Buy13Odds
Pfizer Inc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Pfizer analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Pfizer stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Pfizer Inc, talking to its executives and customers, or listening to Pfizer conference calls.
Pfizer Analyst Advice Details

Pfizer Stock Analysis Indicators

Pfizer Inc stock analysis indicators help investors evaluate how Pfizer stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Pfizer shares will generate the highest return on investment. By understating and applying Pfizer stock analysis, traders can identify Pfizer position entry and exit signals to maximize returns.
Quick Ratio1.09
Trailing Annual Dividend Rate1.55
Fifty Two Week Low33.36
Revenue Growth134.40%
Payout Ratio45.06%
Average Daily Volume Last 10 Day31.31M
Shares Short Prior Month63.54M
Average Daily Volume In Three Month43.62M
Earnings Growth446.80%
Shares Percent Shares Out1.18%
Earnings Quarterly Growth454.50%
Gross Margins65.41%
Forward Price Earnings1.07
Short Percent Of Float1.18%
Float Shares5.61B
Fifty Two Week High61.71
Fifty Day Average54.46
Enterprise Value To Ebitda11.59
Two Hundred Day Average45.15
Enterprise Value To Revenue4.57
Trailing Annual Dividend Yield2.87%
Please check Your Equity Center. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Pfizer Stock analysis

When running Pfizer Inc price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine Pfizer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.